These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34648006)

  • 1. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
    Ghandour B; Dbaibo G; Darwiche N
    Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
    Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M
    Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
    Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
    Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide-based therapeutics for the treatment of cancer.
    Barth BM; Cabot MC; Kester M
    Anticancer Agents Med Chem; 2011 Nov; 11(9):911-9. PubMed ID: 21707481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of bioactive sphingolipids in cancer biology and therapeutics.
    Saddoughi SA; Song P; Ogretmen B
    Subcell Biochem; 2008; 49():413-40. PubMed ID: 18751921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid metabolism in cancer signalling and therapy.
    Ogretmen B
    Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid metabolism enzymes as targets for anticancer therapy.
    Kok JW; Sietsma H
    Curr Drug Targets; 2004 May; 5(4):375-82. PubMed ID: 15134220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles and therapeutic targeting of ceramide metabolism in cancer.
    Wajapeyee N; Beamon TC; Gupta R
    Mol Metab; 2024 May; 83():101936. PubMed ID: 38599378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
    Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide Signaling and p53 Pathways.
    Jeffries KA; Krupenko NI
    Adv Cancer Res; 2018; 140():191-215. PubMed ID: 30060809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
    Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
    Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
    Barui S; Saha S; Yakati V; Chaudhuri A
    Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.
    Li F; Zhang N
    Curr Drug Metab; 2015; 17(1):37-51. PubMed ID: 26526831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy paradox and ceramide.
    Jiang W; Ogretmen B
    Biochim Biophys Acta; 2014 May; 1841(5):783-92. PubMed ID: 24055889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.